Related Experiment Video
Updated: Mar 21, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Rethinking asthma therapy, part 1: transdermal delivery of β2-agonists
Joseph Correa1, Nicole K Brogden1,2
1Department of Pharmaceutical Sciences and Experimental Therapeutics, University of Iowa, Iowa City, IA, United States.
Transdermal drug delivery offers a promising alternative for asthma and allergy treatments, potentially overcoming limitations of current methods like inhalers and injections. This review explores the potential of transdermal systems for beta-2 agonists in asthma management.
Area of Science:
- Pharmacology and Therapeutics
- Respiratory Medicine
- Drug Delivery Systems
Background:
- Asthma and allergies are prevalent global conditions managed with various drug classes, including beta-2 agonists, leukotriene modifiers, and corticosteroids.
- Current administration routes (inhalation, oral, parenteral) present challenges such as improper inhaler technique, reduced oral bioavailability, and poor compliance with injectables.
- Transdermal drug delivery emerges as a potential solution, offering painless, self-administered, and bypasses first-pass metabolism.
Purpose of the Study:
- To review the current literature on transdermal systems for asthma and allergy therapy.
- To specifically examine the potential of transdermal systems for beta-2 agonists in asthma treatment.
Main Methods:
- Literature review of existing studies on transdermal drug delivery for respiratory conditions.
- Focus on beta-2 agonists and their transdermal application in asthma management.
Main Results:
- The body of research on transdermal beta-2 agonists for asthma is currently limited.
- Evidence suggests significant potential for transdermal systems to advance asthma therapeutics.
Conclusions:
- Transdermal drug delivery systems present a viable and potentially superior alternative for administering asthma and allergy medications.
- Further research into transdermal beta-2 agonists could revolutionize asthma treatment paradigms.
Related Concept Videos
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Transdermal Drug Delivery Systems
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Inhaled Medications
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...

